Cite
HARVARD Citation
Ogunniyi, A. et al. (2017). Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency*. Leukemia & lymphoma. 58 (5), pp. 1123-1129. [Online].